The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index
Key facts
- Who runs it
- Jeongsoo Kim
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 13 Feb 2024
- Ended
- 30 May 2024
- Type of study
- Interventional
- Treatments tested
- Lumbar Sympathetic Ganglion Block
- Record updated
- 11 July 2024
Who can take part
- Age
- 19 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Lower extremity pain
- Pain for more than 3 months
- 19 - 85 years
Who cannot take part
- If the patient has previously undergone lumbar sympathetic ganglion removal or neurolysis
- In the presence of vascular disorders in the lower extremities
- If there is a systemic infection or infection at the injection site
- If the patient has allergies to the injected medication
- If the patient refuses to undergo the procedure
- When there are abnormalities in blood coagulation tests
- In the presence of anatomical deformities at the injection site
- In other cases where the researcher deems the patient unsuitable for participation
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The patient, who is experiencing chronic pain in the lower extremities persisting for more than three months, is scheduled to undergo lumbar sympathetic ganglion block. To evaluate the technical success of the sympathetic blockade, temperature and perfusion index (PI) will be measured at one-minute intervals over a 20-minute period before and after the procedure on the treated side and the opposite side foot. Additionally, other variables related to the procedure will be assessed before the procedure, after the procedure, before discharge, and during follow-up outpatient visits or phone surveys at 1 week and 1 month after the procedure.
The group in the trial
- Lumbar Sympathetic Ganglion Block (LSGB)Other group
FS-guided LSGB at L3 level.
Treatment: Lumbar Sympathetic Ganglion Block
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index: A Prospective Observational Study
- Record updated
- 11 July 2024